CryoPort Inc(CYRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 29 at 4:00 PM ET (Korea 10/30 05:00)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.82 | Insider Own | 4.39% | Shs Outstand | 50.6M | Perf Week | 2.58% |
| Market Cap | 0.93B | Forward P/E | - | EPS next Y | 18.06% | Insider Trans | -10.34% | Shs Float | 48.4M | Perf Month | 5.11% |
| Enterprise Value | 0.81B | PEG | - | EPS next Q | -0.18 | Inst Own | 89.62% | Short Float | 5.23% | Perf Quarter | 21.21% |
| Income | -0.04B | P/S | 4.97 | EPS this Y | -156.31% | Inst Trans | 4.8% | Short Ratio | 4.01 | Perf Half Y | 78.27% |
| Sales | 0.19B | P/B | 2.08 | EPS next 5Y | - | ROA | -4.3% | Short Interest | 2.53M | Perf YTD | 90.52% |
| Book/sh | 8.77 | P/C | 2.34 | EPS past 3/5Y | -0.23% 13.68% | ROE | -6.54% | 52W High | -3.12% ($18.88) | Perf Year | 97.94% |
| Cash/sh | 7.83 | P/FCF | - | Sales past 3/5Y | -9.45% 17.49% | ROIC | -6.17% | 52W Low | 140.34% ($7.61) | Perf 3Y | 99.45% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.42% | Gross Margin | 40.16% | Volatility(W/M) | 4.55% 4.12% | Perf 5Y | -77.57% |
| Dividend TTM | - | EV/Sales | 4.33 | Sales Y/Y TTM | -8.01% | Oper. Margin | -21.25% | ATR (14) | 0.69 | Perf 10Y | 809.95% |
| Dividend Ex-Date | - | Quick Ratio | 1.98 | EPS Q/Q | 24.23% | Profit Margin | -21.92% | RSI (14) | 58.8 | Recom | 1.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.08 | Sales Q/Q | 7.74% | SMA20 | 4.16% ($17.56) | Beta | 1.9 | Target Price | $20.12 |
| Payout | - | Debt/Eq | 0.47 | Earnings | 2026/11/5 | SMA50 | 7.93% ($16.95) | Rel Volume | 2.93 | Prev Close | $18.64 |
| Employees | 738 | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | -3.47% 1.65% | SMA200 | 37.82% ($13.27) | Avg Volume(3M) | 0.63M | Price | $18.29 |
| IPO | 2005/1/31 | Option/Short | Yes/Yes | Trades | 4322 | Volume | 1,851,683 | Change | -1.88% |
❄️ Cryoport (CYRX) is a cold-chain logistics company specializing in temperature-sensitive materials for the life sciences industry. It provides integrated solutions spanning ultra-low temperature transportation and storage for cell and gene therapies, vaccines, and biological specimens, operating a life sciences–focused logistics platform that connects biopharmaceutical companies, research institutions, and clinical trial sites on a global scale.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded more than usual. That is 293% of its average volume.
Next earnings report: November 5
7 days to go.
CYRX has a sound balance sheet but weak earning power
Of every $100 in sales, $21.25 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -156.3% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $497. Peers typically go for $76. Compared with its own 1-year average, it is 66% pricier now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -77.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 89.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #12 of 32 in the industry
Based on market cap of $926M.
FAQ
What kind of company is CYRX?
CYRX belongs to the Industrials sector and operates in the Integrated Freight & Logistics industry.
What is the market cap of CYRX?
The market cap of CYRX is approximately $926M, ranking 2,649 within its sector.
What is the 52-week high and low for CYRX?
CYRX has recorded a 52-week high of $18.88 and a low of $7.61.
